Professor, Department of Obstetrics and Gynaecology ; Deputy Director, Prenatal Genetic Diagnosis Centre, CUHK; Director, Pre-implantation Genetic Diagnosis Laboratory, CUHK
Advancements in technologies have revolutionized the genetic landscape. Chromosomal microarray analysis (CMA) becomes a proven method and is implemented to detect gains and losses of DNA and absence of heterozygosity across the genome. Next-generation sequencing technologies have brought opportunities and challenges to genetic testing, its prenatal application is an emerging field. We describe our experience using FetalChip, a CMA for prenatal research developed in our laboratory and describe the role of CMA in the era of genome sequencing.
Learning Objectives
The role of chromosomal microarray analysis (CMA) in prenatal genetic clinical research.
CMA is a well-established and proven technology to identify pathogenic CNVs
The utility of genome sequencing
For Research Use Only. Not for use in diagnostic procedures.
Webinars will be available for unlimited on-demand viewing after live event.
Modern laboratories are under constant pressure to deliver results faster, more accurately, and with unwavering compliance. Organizations that harness next-generation LIMS capabilities gain...
In cell therapy applications, commonly employed cell purification platforms for large-scale isolation of immune or stem cells separate cells based on a single cell surface antigen. Enrichmen...
With advancing food allergy research and emerging therapies, new allergy testing requirements arise. In this context, Basophil Activation Testing (BAT) has emerged as an essential component...
Energy-efficient filtration solutions that reduce hidden chemical exposure from benchtop work and lab equipment to improve overall laboratory safety...
The collection of high-quality genomic DNA remains a major barrier in pediatric and neurodevelopmental research, particularly among children with autism spectrum disorder (ASD) and other neu...